# Impact of COVID-19 on Pregnancy Outcomes: A Phase-Based Analysis from a Spanish Tertiary Hospital (2020–2023)

**Authors:** María-Asunción Quijada-Cazorla, María-Virgilia Simó-Rodríguez, Ana-María Palacios-Marqués, María Peláez-García, José-Manuel Ramos-Rincón

PMC · DOI: 10.3390/jcm14145136 · 2025-07-19

## TL;DR

This study shows that pregnant women with COVID-19 face higher risks of preterm birth and neonatal complications, and vaccination helps reduce hospitalization.

## Contribution

The study provides phase-based insights into the impact of SARS-CoV-2 on pregnancy outcomes in a Spanish hospital from 2020 to 2023.

## Key findings

- Hospitalized pregnant women with COVID-19 had higher rates of preterm birth and cesarean delivery.
- Neonates of infected mothers had lower Apgar scores and higher admission rates to neonatal units.
- Vaccination significantly reduced the risk of hospitalization due to SARS-CoV-2 in pregnant women.

## Abstract

Background/Objectives: Pregnancy has been considered a risk factor for severe SARS-CoV-2 infection, as well as for adverse maternal and neonatal outcomes. This study aimed to assess the clinical impact of COVID-19 on pregnant women managed at a Spanish tertiary care hospital across different phases of the pandemic. Methods: A retrospective observational study was conducted at Dr. Balmis General University Hospital (Alicante, Spain) between March 2020 and May 2023. All pregnant women who received hospital care with confirmed SARS-CoV-2 infection were included. Maternal and neonatal outcomes were analyzed and compared with the 6120 total births recorded during the same period. Results: A total of 249 pregnant women with COVID-19 were included, with 30.8%, 25.0%, and 7.9% hospitalized during each respective pandemic phase. The overall incidence of infection was 41 cases per 1000 births. Hospitalized pregnant women showed significantly higher rates of preterm birth, labor induction (70.4% vs. 47.0%; OR: 2.67; 95% CI: 1.12–6.43), and cesarean delivery (46.9% vs. 24.9%, OR: 2.60; 95% CI: 1.27–5.50). Neonatal outcomes included lower Apgar scores, increased admission to the neonatal unit (25.8% vs. 8.2%, p = 0.007), and a higher rate of neonatal complications (23.3% vs. 7.7%, p = 0.015). Maternal obesity and non-Spanish nationality were associated with more severe maternal disease. Vaccination against SARS-CoV-2 significantly reduced the risk of hospitalization due to the infection (OR: 0.30; 95% CI: 0.13–0.69). Conclusions: Pregnant women admitted with COVID-19 had increased risks of adverse obstetric and neonatal outcomes, underscoring the importance of preventive strategies, such as vaccination.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** labor (MESH:D048949), infection (MESH:D007239), Maternal obesity (MESH:D000079262), preterm birth (MESH:D047928), COVID-19 (MESH:D000086382)
- **Species:** Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12295728/full.md

---
Source: https://tomesphere.com/paper/PMC12295728